These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23093052)

  • 1. Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer's disease.
    Hamuro A
    Aust N Z J Psychiatry; 2013 Jun; 47(6):583. PubMed ID: 23093052
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for Alzheimer's disease in Japan.
    Takeda M; Tanaka T; Okochi M
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of dementia in elderly patients. A review.
    Olsen CE; Poulsen HD; Lublin HK
    Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model.
    Van Dam D; De Deyn PP
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):59-69. PubMed ID: 16095884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
    Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
    Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatments for patients with Alzheimer disease.
    Osborn GG; Saunders AV
    J Am Osteopath Assoc; 2010 Sep; 110(9 Suppl 8):S16-26. PubMed ID: 20926739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study.
    Hager K; Baseman AS; Nye JS; Brashear HR; Han J; Sano M; Davis B; Richards HM
    Alzheimers Res Ther; 2016 Nov; 8(1):47. PubMed ID: 27846868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 14. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT; Pejović V; Miller ML; Graham SM
    Dement Geriatr Cogn Disord; 2009; 27(2):164-72. PubMed ID: 19194105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
    Geerts H; Grossberg GT
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and limitation of newly approved drugs for Alzheimer's disease].
    Hattori H
    Seishin Shinkeigaku Zasshi; 2013; 115(1):22-31. PubMed ID: 23691791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine for dementia?
    Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease.
    Tangwongchai S; Thavichachart N; Senanarong V; Poungvarin N; Phanthumchinda K; Praditsuwan R; Nidhinandana S; Chankrachang S
    Am J Alzheimers Dis Other Demen; 2008 Dec-2009 Jan; 23(6):593-601. PubMed ID: 18845693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
    MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234
    [No Abstract]   [Full Text] [Related]  

  • 20. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
    Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.